Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 8;4(1):e24971.
doi: 10.2196/24971.

Nonprescription Products of Internet Retailers for the Prevention and Management of Herpes Zoster and Postherpetic Neuralgia: Analysis of Consumer Reviews on Amazon

Affiliations

Nonprescription Products of Internet Retailers for the Prevention and Management of Herpes Zoster and Postherpetic Neuralgia: Analysis of Consumer Reviews on Amazon

Pengyi Zhu et al. JMIR Dermatol. .

Abstract

Background: Herpes zoster affects approximately 1 million people annually in the United States, with postherpetic neuralgia as the most common complication. The frequent prescription of opioids as the first-line medication for herpes zoster or postherpetic neuralgia contributes to the increasing health care costs of their treatment. Despite the advent of internet retailers providing alternative products for the prevention and management these conditions, there are limited studies on the availability, ingredients, and consumer preference for the products.

Objective: This study used the internet retailer Amazon to determine the availability of products for the management of herpes zoster and postherpetic neuralgia, and assessed consumer preference based on listed ingredients.

Methods: The internet retailer Amazon was used to perform a search for products related to "shingles" in September 2020. Top products sorted by reviews and ratings were determined to be either shingles-specific (including "shingles" in either the product title or description) or shingles-nonspecific. Analysis of price, rating, type of vehicle, and ingredients was performed. The types of vehicles, ingredients, and percentages of positive and negative reviews related to "shingles" of the product groups were analyzed with a two-tailed two-sample proportions Z-test to assess the difference between shingles-specific and shingles-nonspecific products. Statistical significance was judged at P<.05.

Results: The top 131 products among over 3000 products retrieved were determined based on a rating of 4 or more stars after searching for the term "shingles" on Amazon. Forty-six of the 131 products (35.1%) were shingles-specific. Shingles-nonspecific products were more likely to have positive reviews mentioning "shingles" (P=.005). Vehicles, balms (P=.02), and salves (P=.04) were more likely to be shingles-specific, whereas tablets or capsules (P=.002) were more likely to be shingles-nonspecific. Among the ingredients analyzed, aloe vera was the top-ranked ingredient, included in 29 of the 131 total products (22.1%). Aloe vera (P=.01), lemon balm (P<.001), vitamin E (P=.03), and peppermint oil (P=.008) were more likely to be included in the shingles-specific products, whereas magnesium (P=.01) was more likely to be included in shingles-nonspecific products.

Conclusions: There is an abundance of products and ingredients being used for the management and treatment of shingles with certain ingredients preferred by consumers. There is a discrepancy between approved ingredients and the ingredients preferred by consumers. Furthermore, there are insufficient studies on ingredients used by consumers on internet retailers such as Amazon, and future studies can focus on the effectiveness of popular ingredients to decrease misinformation on the internet.

Keywords: Amazon; consumer preference; customer; herpes; herpes zoster; ingredients; internet; postherpetic neuralgia; shingles; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Similar articles

Cited by

References

    1. Rahmatpour Rokni G, Rathod D, Tabarestani M, Mirabi A, Jha A, de Vita V, Mashhadi Kholerdi H, Feliciani C, Jafferany M, Wollina U, Lotti T, Goldust M. Postherpetic neuralgia and recalcitrant cystic lesions following herpes zoster: A case report and review of treatment options. Dermatol Ther. 2020 Jul 12;33(4):e13793. doi: 10.1111/dth.13793. - DOI - PubMed
    1. Johnson RW, Rice AS. Postherpetic neuralgia. N Engl J Med. 2014 Oct 16;371(16):1526–1533. doi: 10.1056/nejmcp1403062. - DOI - PubMed
    1. Gudin J, Fudin J, Wang E, Haylon T, Patel K, Goss TF. Treatment patterns and medication use in patients with postherpetic neuralgia. J Manag Care Spec Pharm. 2019 Dec;25(12):1387–1396. doi: 10.18553/jmcp.2019.19093. - DOI - PMC - PubMed
    1. Argoff CE. Review of current guidelines on the care of postherpetic neuralgia. Postgrad Med. 2011 Sep 13;123(5):134–142. doi: 10.3810/pgm.2011.09.2469. - DOI - PubMed
    1. Ngo AL, Urits I, Yilmaz M, Fortier L, Anya A, Oh JH, Berger AA, Kassem H, Sanchez MG, Kaye AD, Urman RD, Herron EW, Cornett EM, Viswanath O. Postherpetic neuralgia: current evidence on the topical film-forming spray with bupivacaine hydrochloride and a review of available treatment strategies. Adv Ther. 2020 May 15;37(5):2003–2016. doi: 10.1007/s12325-020-01335-9. http://europepmc.org/abstract/MED/32297285 10.1007/s12325-020-01335-9 - DOI - PMC - PubMed

MeSH terms

Substances